←
HFUND273 posts
HFUND avatar

HFUND

@theonepractice

#1 ranked equity research analyst (Media sector - JP Morgan); #1 ranked high yield analyst (TMT - RBS). Now, business owner, investor and turnaround expert

◷ Joined December 2021▧ 14 Photos and videos
HFUND avatar
HFUND@theonepractice·6 Sep 2022

“Everyone” is saying: invest in high quality; free cash flow; safe investments. What does that imply for highest return allocation? #investing

HFUND avatar
HFUND@theonepractice·30 Mar 2022

Dear Bitcoin Maxis: Bitcoin is, without question, a pristine and irreplaceable asset - however, it is a cryptocurrency and there are others that do have valuable use cases. Comments suggesting otherwise are only going to slow down adaption #bitcoin #crytpo

HFUND avatar
HFUND@theonepractice·28 Mar 2022

Is it just me or have you noticed the increased monetization initiatives being implementing on $twtr Is this the strategy investors have been waiting for? I’m long $twtr

HFUND avatar
HFUND@theonepractice·27 Mar 2022

90% of #bitcoin hodlers are still accumulating, yet 90% get excited when the price increases 🤔 Do you get excited when the price of something you’re wanting to buy goes up?

HFUND avatar
HFUND@theonepractice·24 Mar 2022

Overall, nothing significantly new but good to see that management remains consistent with its strategy. This is an easy 10 bagger but should be considered very high risk and a long-term hold. I’m long

HFUND avatar
HFUND@theonepractice·24 Mar 2022

23andMe not very well understood. Primarily that the biotech and DTC components work together as synergistic units

HFUND avatar
HFUND@theonepractice·24 Mar 2022

Drug development. Most exciting part of company. Over 100 scientists. Patnership with GSK. 2 drugs in phase one and 40 potential have been identified. Even if one takes hold, it will be a game changer for $me

HFUND avatar
HFUND@theonepractice·24 Mar 2022

Lemonaid Health: most people do not have access to their genetic information as part of their primary care. Genetics based care at scale is a key component of $me’s strategy. Could largely replace the primary care function

HFUND avatar
HFUND@theonepractice·24 Mar 2022

40% of customer’s return on a quarterly basis. Subscription service leveraged off this demand and helps justify additional and more consistent investments in the core DTC business

HFUND avatar
HFUND@theonepractice·24 Mar 2022

Re-affirmed commitment to DTC business which gives individuals access to their genomic data as the current healthcare model is not factoring this into the current delivery of healthcare

HFUND avatar
HFUND@theonepractice·24 Mar 2022

Notes following interview with Anne Wojcicki, co-founder and CEO of 23andMe $me Nothing significantly new but interesting nonetheless ⬇️

HFUND avatar
HFUND@theonepractice·23 Mar 2022

Anne Wojcicki, co-founder and CEO of 23andMe, is being interviewed by Motley Fool in a members only forum today at 3pm (EST). $me is one of my 10-100 bagger investments. I’ll be summarizing any interesting updates after the interview.